The award is part of the Military Prototype Advancement Initiative, funded by the Department of Defense and issued through the Medical Technology Enterprise Consortium, a collaboration of industry and academia to facilitate R&D activities with USAMRDC and other government agencies.
The PROMPT Study will give the trauma community the most compelling data yet on where Partial REBOA using pREBOA-PRO will fit in their toolkit to improve patient outcomes and save lives.
Vivacelle Bio, Inc., a privately held life science company focused on the development of treatments for hypovolemia in shock including septic shock and hemorrhagic shock, announced the successful completion of its Phase IIa clinical trial of VBI-S in septic shock patients with severe hypovolemia.
Advanced Technology International (ATI) and TechConnect today announced 25 finalists who will pitch on September 28, 2022 at Defense TechConnect Innovation Summit for $200,000 in non-dilutive awards. These candidates receive membership from four consortia with a combined $50B in federal contracting authority including: Medical CBRN Defense Consortium (MCDC), Countering Weapons of Mass Destruction Consortium (CWMD), Medical Technology Enterprise Consortium (MTEC), and Senior Healthcare Innovation Consortium (SHIC).
This handheld device is for Army battalion aid stations, brigade support aid stations,and field hospitals for triaging and evacuation decision making. Officials of the Medical Technology Enterprise Consortium (MTEC) in Summerville, S.C., issued a request for project proposals (MTEC-22-08-BDA) on Friday for the Burn Digital Assessment project.
These efforts have been successful, and Dr. Biris’ university spinout venture NuShores received a fourth award in FY20 by the U.S. Army’s Medical Research and Development Command’s Clinical and Rehabilitative Research Program (CRMRP) via an Other Transaction Agreement (OTA) competitively awarded through the Medical Technology Enterprise Consortium (MTEC). This transition of the initial NuCressTM manufacturing process from the JWMRP to the MTEC focuses on the optimization of the manufacturing process by investigating multiple and consecutive iterations of automation to improve quality, cost and efficiency. The deliverable is to demonstrate the feasibility of producing the NuCressTM bone void filler scaffold by a fully automated, intelligent production system with real-time in-process quality monitoring and control.
The award from the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command, is sponsored and will be managed by the Naval Medical Research Center (NMRC) to advance medical treatments for combat wounds and burns.
“Through MTEC, NMRC is harnessing the innovation of academia and the biotechnology sector to develop and eventually deliver technology to the warfighter,” said Thomas Dunn, acting program manager of NMRC’s Naval Advanced Medical Development department. “MTEC helps survey the scope of innovative research, and to see how that research can be used to meet the needs of military medicine.”
How exactly the ReHeal Glove got to where it is now—flush with funding and undergoing various rounds of testing—is largely due to the role of the Medical Technology Enterprise Consortium (MTEC), a nonprofit corporation that operates as the premier facilitator and collaborator across the entire DOD. Indeed, if it weren’t for MTEC, the near decade-long effort to develop the ReHeal Glove may have withered on the vine. Instead, it provides a promising medical option for millions.
Apheresis services firm Terumo Blood and Cell Technologies has entered into a contract with the Medical Technology Enterprise Consortium (MTEC), which is an Other Transaction Agreement (OTA) with the US Army Medical Research and Development Command.
